Moolec Science SA (NASDAQ:MLECW – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totaling 18,390 shares, a growth of 40.0% from the December 31st total of 13,137 shares. Based on an average trading volume of 812,977 shares, the short-interest ratio is currently 0.0 days. Based on an average trading volume of 812,977 shares, the short-interest ratio is currently 0.0 days.
Moolec Science Stock Performance
MLECW stock traded down $0.00 on Friday, hitting $0.01. 84,032 shares of the company were exchanged, compared to its average volume of 573,047. Moolec Science has a twelve month low of $0.00 and a twelve month high of $0.05. The business’s fifty day moving average is $0.01 and its two-hundred day moving average is $0.01.
Moolec Science Company Profile
Moolec Science is a biotechnology company focused on developing gene-edited livestock as living bioreactors to produce therapeutic proteins. The company leverages CRISPR/Cas9 and related gene-editing technologies to introduce human genes into the genome of pigs, enabling the secretion of complex human proteins in sow’s milk. By combining advanced genetic engineering with traditional livestock breeding, Moolec Science aims to address scalability and cost challenges associated with conventional biologics manufacturing.
The company’s pipeline centers on the production of large multimolecular proteins, including coagulation factors and antibody fragments, for rare diseases and life-threatening conditions.
Recommended Stories
- Five stocks we like better than Moolec Science
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Gold’s getting scarce.
- Trump’s Final Shocking Act Begins February 24
- Become a 2x better options trader (in 2 days)
- NEW: Gold makes history
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
